CLSI NBS05

Newborn Screening for Cystic Fibrosis, 2nd Edition, NBS05Ed2E

Clinical and Laboratory Standards Institute, 12/01/2019

Publisher: CLSI

File Format: PDF

$90.00$180.00

Description

Published:01/12/2019

Pages:86

File Size:1 file , 7 MB

Note:This product is unavailable in Russia, Belarus

This guideline describes newborn screening laboratory tests for detecting analytes and genetic markers associated with cystic fibrosis (CF). It includes both the first-tier and second-tier screening tests performed on newborn dried blood spot specimens, as well as the screening strategies for identifying newborns at increased risk for developing CF.

More CLSI standard pdf

CLSI VET02-A3

Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters for Veterinary Antimicrobial Agents; Approved Guideline - Third Edition, VET02A3E

$90.00 $180.00

CLSI I/LA30-A

Immunoassay Interference by Endogenous Antibodies; Approved Guideline, ILA30AE

$108.00 $216.21

CLSI M23-A3

Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters; Approved Guideline--Third Edition, M23A3E

$145.00 $290.74

CLSI M50-A (R.2018)

Quality Control for Commercial Microbial Identification Systems; Approved Guideline, M50AE

$90.00 $180.00